Clinical course and treatment of anti-HMGCR antibody–associated necrotizing autoimmune myopathy

OBJECTIVE: We examined a cohort of Australian patients with statin exposure who developed a necrotizing autoimmune myopathy (NAM) associated with a novel autoantibody against 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) and describe the clinical and therapeutic challenges of managing thes...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramanathan, Sudarshini, Langguth, Daman, Hardy, Todd A., Garg, Nidhi, Bundell, Chris, Rojana-Udomsart, Arada, Dale, Russell C., Robertson, Thomas, Mammen, Andrew L., Reddel, Stephen W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386794/
https://www.ncbi.nlm.nih.gov/pubmed/25866831
http://dx.doi.org/10.1212/NXI.0000000000000096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386794/
https://www.ncbi.nlm.nih.gov/pubmed/25866831
http://dx.doi.org/10.1212/NXI.0000000000000096

Ejemplares similares